Pfizer to seek US permission for COVID booster to target delta variant

COVID-19 vaccines: Pfizer/BioNTech 'booster' shot turbo-charges immunity

The bad news is that two shots of Pfizer's COVID-19 vaccine loses efficacy against infection and preventing symptomatic disease after just six months.

Huntsville infectious disease specialist responds to Pfizer push for COVID-19 booster shot approval

HUNTSVILLE, Ala. - Pharmaceutical company Pfizer announced Thursday the company is looking for U.S. authorization of a third dose of its COVID-19 vaccine. The company says it could boost immunity dramatically, but health agencies aren't sold yet.Pfizer is searching for approval for the booster shot, saying they want to ensure the masses are protected from COVID-19 and its variants. Pfizer researchers say a third shot could increase protective an…

Pfizer anticipating booster needed to provide better efficacy, but federal regulators say not yet

MILWAUKEE (CBS 58) -- Pfizer/BioNTech has announced it anticipates a third COVID booster shot will provide the highest continued efficacy against the virus. Shortly after the drug maker made that statemen

Penn researcher weighs in on potential COVID-19 vaccine booster shots

Pfizer announced Friday it will ask the FDA for authorization of a third booster shot of its COVID-19 vaccine, timed for 6 to 12 months after the second dose.

Booster shots aren't necessary right now, US health agencies say. Pfizer is seeking authorization anyway.

Pfizer announced on Thursday that it's seeking authorization for a booster shot - a third dose of its existing coronavirus vaccine - next month.

Pfizer to seek authorization for COVID booster as Delta variant spreads